Calithera Biosciences Promotes Emil T. Kuriakose, MD, to Chief Medical Officer
-- Dr. Kuriakose to succeed Keith Orford, MD, PhD, who will assume seat on Calithera Board of DirectorsSOUTH SAN FRANCISCO,...
News
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results on November 12, 2021
DUBLIN, Ireland and CHICAGO, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical...
Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial
--KEAPSAKE interim analysis demonstrated lack of clinical benefit among patients treated with telaglenastat --Company will focus on advancing newly acquired...
BioCryst Presents New Data Showing Sustained Reduction of HAE Attack Rates and Improved Patient Satisfaction After Patients Switch to ORLADEYO® (berotralstat)
Data from APeX-S showed patients had more than 80 percent attack free months after switching to ORLADEYO from injectable prophylactic...
Silence Therapeutics Welcomes Frazier Life Sciences as New Key Shareholder
Silence Therapeutics Welcomes Frazier Life Sciences as New Key Shareholder 5 November 2021 LONDON, Silence Therapeutics plc, AIM: SLN and...
Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational COVID-19 Vaccine COVAXIN™ (BBV152) for Children Ages 2-18 Years
COVAXIN™ (BBV152) was recently awarded Emergency Use Listing by the World Health OrganizationPediatric EUA submission based on immuno-bridging clinical trial...
Release date of nine-month interim report (Q3) 2021 for ALK and audio cast
On Thursday, 11 November 2021, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its nine-month interim report...
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering
COPENHAGEN, Denmark, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology...
Virbac : Declaration of the number of shares and voting rights October 2021
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Smart Immune Announces Acceptance of Two Abstracts Covering Preclinical Research and Clinical Data at the American Society of Hematology
Data Presented at ASH Underscores the Potential of the Smart-Immune Platform That Can Generate ex-vivo T- cell progenitors and NK-...
Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics
Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics Study...
Notice of Extra General Meeting in Acarix AB
Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby...
Boosh Creates 5th Revenue Stream; Selling To The Food Service Industry
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the...
Izotropic Appoints Breast CT Expert as Head of Imaging Technology
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing...
Establishment Labs Announces Jeffrey Bettinger Has Joined the Company as Global Head of People
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
Ault Global Holdings’ Subsidiary Gresham Worldwide Books Orders Totaling Approximately $15.2 Million During the Last Two Quarters
LAS VEGAS--(BUSINESS WIRE)--$AGH #AmosKohn--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), today announced that its...
Nomination Committee in IRLAB Appointed Ahead of Annual General Meeting 2022
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB (Nasdaq Stockholm:IRLAB A); Members of the nomination committee...
Invitation to the Presentation of IRLAB´s Interim Report January – September 2021
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB Therapeutics AB (publ) will publish the interim...
Relief Reports U.S. Collaboration Partner’s Emergency Use Authorization Request for ZYESAMI/RLF-100 (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure was Declined by U.S. FDA
GENEVA, SWITZERLAND / ACCESSWIRE / November 5, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company seeking to...
1health Prepares Employers for Upcoming COVID-19 Vaccine Mandate with New, Turnkey Compliance Tool
SAN FRANCISCO, Nov. 4, 2021 /PRNewswire/ -- 1health, a leading cloud platform for modern diagnostic test management and a pioneer...